Onconetix (ONCO) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Onconetix is the larger company by market cap ($3.4 million vs $3.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ONCO | SILO |
|---|---|---|
| Share price | $0.6543 | $1.45 |
| Market cap | $3.43M | $2.98M |
| 1-day change | +9.56% | +0.69% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $310.39 | $-4.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $209.50 | $10.44 |
| 52-week low | $0.58 | $1.30 |
| Distance from 52-week high | -99.69% | -86.11% |
| Average volume | 2.23M | 114.43K |
| Shares outstanding | 5.24M | 2.05M |
| Employees | 2 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Healthcare · Biotechnology · 2 employees
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Healthcare · Biotechnology · 3 employees
ONCO vs SILO FAQ
Which is bigger, Onconetix or Silo Pharma?
Onconetix (ONCO) is larger, with a market capitalization of $3.43M compared with $2.98M for Silo Pharma (SILO).
Are Onconetix and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.